Terms of Use

The following Terms of Use govern and apply to your use of this and any other website maintained by Nanscope Therapeutics, Inc.  including its subsidiaries or affiliates (collectively referred to as “Nanoscope”).

Access and/or use of this Nanoscope Therapeutics website are subject to the terms and conditions set forth herein and all applicable laws, statutes, and/or regulations. Nanoscope Therapeutics may revise these Terms of Use from time to time without further notice by updating this posting. Your access or use of this Nanoscope Therapeutics website indicates your acceptance of these terms.

Health Information

This Nanoscope Therapeutics website does not, and is not intended to, provide medical advice. Users of this Nanoscope Therapeutics website should be aware that any product(s) under development described herein have not been found safe or effective by any regulatory agency and are not approved for any use outside of clinical trials or other research use. The information presented on this Nanoscope Therapeutics website should not be interpreted or construed in any way as a replacement or substitution for medical advice provided by your doctor or healthcare provider. It is important that you discuss your treatment options and any questions that you may have with your doctor or healthcare provider.

Website Information, News, & Press Releases

This Nanoscope Therapeutics website may contain or post information, news, and/or press releases, the content of which is deemed to be accurate or current only as of the date of the particular information, news, press release, or posting. Nanoscope Therapeutics does not update press releases once they have been made public. Information, news, and/or press releases on this website may also contain forward-looking statements, which are subject to risks and uncertainties. All statements, other than statements of fact, including those statements with respect to Nanoscope Therapeutics’ business or product development activities, contain forward-looking statements. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements.

Intellectual Property: Copyrights & Trademarks

The Nanoscope Therapeutics company name and logo, and all product names, servicemarks or other trademarks, regardless of whether or not they appear with a trademark symbol, are trademarks of Nanoscope Therapeutics or its affiliates unless otherwise noted. Use, reproduction, copying, or redistribution of these trademarks, without the prior written permission of Nanoscope Therapeutics is prohibited.

The entire content of this Nanoscope Therapeutics website, including any images or text, is protected by copyright. This Nanoscope Therapeutics website may not be copied, distributed, reused, reposted, or otherwise exploited. It is the policy of Nanoscope Therapeutics to enforce its intellectual property rights to the fullest extent permitted under law. The use of these trademarks, copyrights, or other materials, is expressly prohibited and may be in violation of applicable laws, statutes, and/or regulations.

Third Party Websites

Nanoscope Therapeutics’ website may include links to websites maintained or controlled by others. Nanoscope Therapeutics is not responsible for the contents or use of any information, products, or services that may be offered at these websites.

Disclaimer of Warranties and Limitation of Liability

All information on this Nanoscope Therapeutics website is provided “AS IS“. Nanoscope Therapeutics makes no warranties or representations as to the accuracy of information presented on this Nanoscope Therapeutics website and disclaims all warranties, express or implied, to the full extent permitted by applicable law.

Nanoscope Therapeutics shall not be held responsible for any action or inaction that is based on the information presented on this Nanoscope Therapeutics website, and all users of this Nanoscope Therapeutics website agree that all access and use of this Nanoscope Therapeutics website, and any and all content presented on this Nanoscope Therapeutics website, is at the user’s own risk.

Any communication or material you transmit to Nanoscope Therapeutics via this Nanoscope Therapeutics website or internet electronic mail is transmitted by you on a nonconfidential basis. Nanoscope Therapeutics makes no promise, express or implied, not to use such communication or material for any purpose whatsoever, including reproduction, publication, broadcast, and posting.

Our Contact Information:

Nanoscope Therapeutics, Inc.
Attention: Website Administrator
1312 Brown Trail
Bedford, TX 76022, USA

Nanoscope Therapeutics, Inc.
Trinity Towers
2777 N. Stemmons Fwy.
Dallas, TX 75207
(817) 857-1186
  • Dr. Samarendra Mohanty, PhD |  Co-Founder & President

    Samarendra Mohanty (Co-Founder/President) is an inventor & serial entrepreneur with 20+ years experience in Biomedical Sciences. He is Co-Founder of several Biotechs and Biomedical device /diagnostic companies (developed & commercialized $100K+ biomedical instruments.)

    Samar obtained M.Tech in Applied Optics from the Indian Institute of Technology-Delhi and a PhD in (Bio)Physics from the Indian Institute of Sciences-Bangalore.

    His extensive Biomedical Technologies experience includes serving as Professor/Senior Scientist at the University of Texas;  University of California, Irvine; Center for Adv. Tech (India); Int. Mol. Biotech (Germany); Univ. Pavia (Italy); NUS (Singapore); and University of St. Andrews (UK). He has authored over 200 international patents and publications in leading journals including Nature and Nature Photonics.

    He is the Principal Investigator for major grants from the National Eye Institute including Audacious Goal Initiative and Bioengineering Research grants. He serves on the editorial board of journals and chairs an international conference on optogenetics. He is the winner of a 2019 Healthcare Heroes award (Fort Worth Business Press), Retinal Organoid Challenge Award, Audacious Goal Initiative Award (NIH), Finalist of Tech Titan, and NIH-Director’s Innovator Award.